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INTRODUCTION 
Cardiovascular diseases are the main cause of mortality 
all around the world, though; the number of death 
resulting from cardiovascular diseases has declined 
compared to 40 years ago owing to the progress in 
diagnostic and surgical technologies particularly 
cardiovascular angiography and catheterizations.
1,2
 
Coronary angiography is an invasive examination for the 
individuals diagnosed with coronary artery disease whose 
use has gradually increased.
3
 
In most cases, invasive diagnostic procedures, is 
accompanied by stress and anxiety in patients.
4
 Stress and 
anxiety raises psychological and physiological activity of 
the body such as heart rate, blood pressure and cardiac 
output and is more probably to be very harmful for 
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patients with myocardial infarction or other heart 
problem.
5
 
Most of the factors involved in a person's stress level are 
having the history of angiography, pain, anxiety, 
unfamiliarity of environment and fear.
6,7
 There are 
different ways to deal with anxiety in patients, among 
which consuming sedatives and antiarrhythmic drugs 
such as diphenhydramine and diazepam can be pointed 
out.
8
 
Before coronary angiography, different drugs may be 
administered to the patients, such as analgesics to calm 
them, atropine sulfate to help prevent bradycardia and 
vasovagal responses or an antihistamine such as 
diphenhydramine-chloride.
9
 
However, in none of the resources, the use of this 
medication is not definitely recommended; rather 
applying them has been conditioned to careful checking 
of the patient's history. But unfortunately without having 
proper knowledge of the patient's history all patients in 
most centers receive medication before angiography.
9
                  
Coronary angiography is a common procedure but 
sometimes can have major side effects, such as cardiac 
arrhythmia, kidney damage, blood clot formation which 
may lead to heart attack or brain stroke, hypotension, 
pericardial effusion, and death during procedures. The 
risk of major side-effects and serious complications is 
low and mostly occur in people who have serious heart 
disease or undergo coronary angiography in an 
emergency situation. 
Most of the side effects are minor and include bleeding, 
bruising, blood vessel damage, allergic reactions to 
contrast agents, catheter site infection etc. In general, the 
angiography is almost a safe procedure and if the 
preparations are made, there will be less risk of 
complications.
11,12
 
Therefore, identifying the complications of various 
premedication on patients' anxiety, as well as the 
complications and duration of angiography, and 
comparing them with each other as main objective of the 
present study, can provide us with insight about how to 
implement this diagnostic and therapeutic method.  
METHODS 
The present study was a double-blind clinical trial that 
included 150 patients with age range of 35 to 75 years 
who were randomly chosen among the patients 
undergoing coronary angiography and hospitalized in 
Imam Khomeini Hospital in Ardabil. 
Two premedication groups (each consisting 50 patients), 
received ordinary drugs used before angiography 
including diazepam + promethazine or hydrocortisone or 
midazolam and the placebo group received only routine 
care before angiography. The information related to the 
patients' demographic data, history of mental illness, 
history of consuming sedatives and anticoagulants, the 
risk factors of cardiovascular disease, disease-related 
information, and the site of catheterization were written 
down, and their hemodynamic parameters (systolic and 
diastolic blood pressure, the number of pulse rate, 
respiratory rate) were recorded at intervals of an hour 
before angiography and during angiography.  
Additionally, spielberger anxiety questionnaire and the 
complications of angiography were completed. In this 
study, subjects were randomly assigned to three groups. 
In order to control the intervening factors and prevent 
patients from communicating with each other, the 
protocols of premedication were at nurses' disposal. 
Then, they along with providing patients with ordinary 
cares before angiography, randomly injected  diazepam 
(5 mg) + promethazine (25 mg) + intravenous 
hydrocortisone (100 mg) to 50 patients, 0.02 mg/kg of 
intravenous midazolam to other 50 patients,  and 2 mL of 
normal saline without pre-medication to remaining 50 
patients.  
The level of anxiety was evaluated in patients based on 
spielberger anxiety inventory and clinical symptoms. The 
implemented technique for all patients was femoral-
artery-access; and the used contrast media were 
omnipaque and visipaque. The duration of angiography, 
the access time, the volume of used contrast media and 
the complications of angiography were recorded until a 
week after angiography in the questionnaires.  
Arterial bleeding requiring haemostasis or techniques 
other than compression, hematoma larger than 3 cm, 
vasovagal reflexes requiring blood pressure and heart rate 
control were taken as complications of angiography. In 
the cases which having pain in the site of angiography, 
swelling, bruits in the route of the femoral artery, etc. 
colour Doppler ultrasound was taken to confirm the 
diagnosis of pseudo aneurysm. Three days after 
angiography serum creatinine and urea were checked to 
rule out kidney damage. In patients doubt to vascular 
complications at the catheterization site, arterial colour 
Doppler ultrasound was requested at the site of 
angiography.  
Collected data were analysed, using SPSS.19, by 
descriptive and analytical statistical methods. The 
significance level for all the above mentioned tests was 
set at 0.05. This study was conducted after receiving 
approval from the research ethics committee and being 
registered on IRCT with number 
IRCT20131020115096N1. 
RESULTS 
The patients in all three groups were similar to each other 
regarding gender, age and BMI, diagnosis of the disease, 
history of heart disease, taking sedative, consuming 
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anticoagulant, smoking and other risk factors for 
cardiovascular disease, as well, all patients underwent 
elective angiography. Therefore, there was no statistically 
significant difference among the three groups in these 
respects (Table 1). The comparison of hemodynamic 
variables showed statistically significant difference only 
in diastolic blood pressure (P = 0. 032). No significant 
difference was detected among three groups of patients 
concerning access time, volume of angiography contrast 
agent, and the duration of angiography (Table 2). 
 
Table 1: Demographic variables by groups. 
Group variables Diazopam N = 50 Placebo N =  50 Midazolam N = 50 p-value 
Male 
Female 
26 (52%) 
24 (48) 
24 (48%) 
26 (52) 
22 (44%) 
28 (56) 
0.8 
Age  57.6 56.4 57.1 0.8 
BMI  27.2 28.2 27.6 0.8 
Elective angiography 50 (100%) 50 (100%) 50 (100%) 0.6 
Hypertansion history 34 (68%) 40 (80%) 35 (70%) 1 
Diabetus history 9 (18%) 13 (26%) 14 (28%) 0.4 
Smoking 12 (24%) 15 (30%) 12 (24%) 0.6 
Sedation uses 3 (6%) 4 (8%) 3 (6%) 0.7 
Taking anticoagulant 4 (8%) 3 (6%) 3 (6%) 0.6 
Table 2: Hemodenamic variables in three groups before angiography and during angiography. 
Group variables Diazopam N = 50 Placebo N = 50 Midazolam N = 50 p-value 
SBP 6.7±3.4 7.8±3.1 4.1±4.4 0.25 
DBP 9.4±1.9 13.9±3.3 13.2±3.4 0.03 
PR 2.6±1.5 3±1.5 0.6±0.1 0.35 
RR 7.6±1.2 3.1±1.3 3.7±2.1 0.1 
Access time (second) 22.8±5 22.7±4 24±4 0.4 
The volume of contrast agent (cc) 54.5±7.5 52.5±5.4 51.3±5.5 0.06 
Angiography duratoion time (min) 5.1±22 4.1±18 4.2±16 0.06 
Table 3: Anxity levels in three groups. 
Group variables Diazopam N = 50 Placebo N = 50 Midazolam N = 50 p-value 
Anxiety level 
Mild 40 (33%) 42 (35.1%) 39 (32%) 0.9 
Moderate and low 10 (34.8%) 8 (26.1%) 11 (39.1%) 0.7 
Table 4: Side effects due to angiography in three groups. 
Group variables Diazopam N = 50 Placebo N = 50 Midazolam N = 50 p-value 
Allergic reactions 1 (2%) 1 (2%) 1 (2%) 1 
Bleeding  1 (2%) 1 (2%) 1 (2%) 1 
Vasovagal reactions 4 (8%) 3 (6%) 3 (6%) 0.9 
Hematuma  5 (10%) 5(10%) 6 (12%) 0.9 
Pseudo-aneurysm 1 (2%) 1 (2%) 0 0.4 
 
The comparison of anxiety level among three groups of 
patients showed statistically significant differences 
between the three groups in terms of level of anxiety. It 
should be mentioned that anxiety level in none of the 
patients was higher than average (Table 3). 
The evaluation of the complications from the procedure 
in all patients revealed that hematoma complications and 
vasovagal responses with16 and 10 cases had the highest 
frequency compared to other complications in three 
groups, but the difference among the three groups of 
patients was not statistically significant. It is necessary to 
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be noted that none of the patients had complications 
related to kidneys, brain or lung (Table 4).  
DISCUSSION 
Drug therapy with benzodiazepines is used in most 
cardiac catheterization centers during angiography and 
angioplasty, but the studies done on their efficacy and 
benefits is limited. The study showed that the 
hemodynamic parameters except for the difference 
between diastolic blood pressure before receiving the 
drug and during angiography didn’t vary significantly in 
patients undergoing coronary angiography and those 
taking premedication before angiography. And the 
diastolic blood pressure difference in the group receiving 
diazepam + promethazine + hydrocortisone was lower 
than the other two groups, which was not consistent with 
the result of Kazemi et al.'s study indicating a significant 
reduction in diastolic blood pressure for patients in the 
midazolam group.
9
 
Most patients undergoing cardiac catheterization have a 
history of heart disease and receive several medications 
such as beta-blockers and blood pressure lowering drugs. 
Therefore, physiological responses are mostly affected by 
these drugs. 
In this study, patients in all three groups had higher blood 
pressure and heart rate during angiography than before 
angiography, which indicates that people experience 
greater amount of anxiety during angiography. 
Bally et al. showed that anxiety by activating the 
sympathetic nervous system causes increased heart rate, 
blood pressure and cardiac output. And when patients are 
anxious or experience more discomfort, it is possible that 
physiological response along with increased heart rate 
and blood pressure to be observed.
7
 
In this study, the patients experienced maximum anxiety 
during angiography. The study by Papolo and Kurdesko 
has found that when patients are faced with a stressful 
situation they experience heart palpitations.
13
 Therefore, 
in this study it appears that angiography as a stress factor 
raises the degree of sympathetic activity and thus results 
in increased heart rate in patients. 
Overall, in this study, the comparison of two stages of 
hemodynamic parameters' measurements (one hour 
before the injection of pre-medication and during 
angiography) revealed no significant difference among 
three groups. 
Accordingly, the hypothesis, that the hemodynamic 
parameters change in the patients undergoing coronary 
angiography who receive drug is identical to the control 
group, which supports the Haneafy et al finding.
10
 
In this study, vascular complications were observed in 
14% of patients. The complications were mostly common 
among females, the patients with short stature, and those 
with a history of HTN. 
In the midazolam group one of the patient showed 
agitations during the procedure which was considered as 
a midazolam side effect. Although Midazolam is taken as 
a sedative into account, in some patients, it can cause 
restlessness and agitation. However, there was no 
statistically significant difference in respect of side 
effects among the three groups. 
Currently, in most of Cardiac catheterization centers, 
intravenous Midazolam is injected to the patients, and if a 
patient complains about severe anxiety and asks for a 
drug, 5-10 mg of diazepam is administered orally. 
In a study by Bergeron et al., oral midazolam had been 
administered instead of intramuscular injection due to its 
faster and better absorption. However, based on the 
results of this study, oral diazepam also had little effect 
on anxiety and pain. In addition, the number of 
angiographic complications didn't decrease.
11
 
Alamri et al in their study explored that diazepam and 
chlorpheniramine didn't reduce the complications of 
angiography and anxiety.
12
 In Kazemi et al.'s study, as 
well, intramuscular diazepam and intravenous midazolam 
had no effect on anxiety of the patients.
9
 
High levels of anxiety can make the patient not cooperate 
with the operator during the procedure and in turn 
increase the access time or raise the number of puncture 
and thus prolong the time of angiography, and due to 
higher risk of complications in patients. This study 
showed that medication with benzodiazepines compared 
with the placebo has no effect on patients' anxiety, 
angiography complications and time. 
In this study, the level of anxiety in patients was 
measured with Spielberger scale, which is one of the 
reliable scales for evaluation the patient's anxiety. We 
obtained that in this study, all patients had mild or 
moderate anxiety and so the need to use premeditations to 
reduce patients' anxiety before angiography becomes 
pale. 
Moreover, unnecessary injection of these drugs may be 
associated with complications in some cases and increase 
hospital costs for patients. 
So this study does not support the routine use of these 
drugs except for emergencies. 
The improvement of angiographic and cardiac 
catheterization techniques, using more advanced 
equipment and smaller arterial sheaths, and mechanical 
closure devices (vascular closure devise), the increased 
level of awareness among people and educating them 
about cardiovascular disease and the heart disease 
diagnostic methods have been reduced the complications 
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of cardiac catheterization and angiography, as well as the 
patients' anxiety. 
On the other hand, the angiography procedure lasts only 
for a short while (a few minutes) which also decreases the 
complications and the necessity of premedication before 
angiography. 
CONCLUSION 
The results showed that routine injection of 
premedication doesn’t have any effect on anxiety of 
patients who undergo coronary angiography and doesn't 
reduce the duration and complications of angiography. 
Thus, it is recommended that before such aggressive 
methods, the premedication in the emergency cases be 
administered. This need for a careful examination of the 
patients which by doing this, the patients wouldn't receive 
undue drug therapy. 
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